Format
Items per page
Sort by

Send to:

Choose Destination

Links from Books

Items: 8

1.

Antitumor effects of a human dimeric antibody fragment 131I-AFRA-DFM5.3 in a mouse model for ovarian cancer.

Zacchetti A, Martin F, Luison E, Coliva A, Bombardieri E, Allegretti M, Figini M, Canevari S.

J Nucl Med. 2011 Dec;52(12):1938-46. doi: 10.2967/jnumed.110.086819. Epub 2011 Nov 8.

2.

Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results.

van Dam GM, Themelis G, Crane LM, Harlaar NJ, Pleijhuis RG, Kelder W, Sarantopoulos A, de Jong JS, Arts HJ, van der Zee AG, Bart J, Low PS, Ntziachristos V.

Nat Med. 2011 Sep 18;17(10):1315-9. doi: 10.1038/nm.2472.

PMID:
21926976
3.

Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer.

Julien DC, Behnke S, Wang G, Murdoch GK, Hill RA.

MAbs. 2011 Sep-Oct;3(5):467-78. doi: 10.4161/mabs.3.5.16089. Epub 2011 Sep 1. Review.

4.

Ovarian cancer development and metastasis.

Lengyel E.

Am J Pathol. 2010 Sep;177(3):1053-64. doi: 10.2353/ajpath.2010.100105. Epub 2010 Jul 22.

5.

(177)Lu- labeled MOv18 as compared to (131)I- or (90)Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts.

Zacchetti A, Coliva A, Luison E, Seregni E, Bombardieri E, Giussani A, Figini M, Canevari S.

Nucl Med Biol. 2009 Oct;36(7):759-70. doi: 10.1016/j.nucmedbio.2009.05.004. Epub 2009 Jul 29.

PMID:
19720288
6.

Functional folate receptor alpha is elevated in the blood of ovarian cancer patients.

Basal E, Eghbali-Fatourechi GZ, Kalli KR, Hartmann LC, Goodman KM, Goode EL, Kamen BA, Low PS, Knutson KL.

PLoS One. 2009 Jul 20;4(7):e6292. doi: 10.1371/journal.pone.0006292.

7.

Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor.

Figini M, Martin F, Ferri R, Luison E, Ripamonti E, Zacchetti A, Mortarino M, Di Cioccio V, Maurizi G, Allegretti M, Canevari S.

Cancer Immunol Immunother. 2009 Apr;58(4):531-46. doi: 10.1007/s00262-008-0575-5. Epub 2008 Aug 15.

PMID:
18704410
8.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk